C&EN article by Shi En Kim
November 13, 2022 | A version of this story appeared in Volume 100, Issue 40
IN BRIEF:
The lack of gravity in space opens up unique opportunities for drug design and development. With the influx of commercial entities providing access to low-Earth orbit, both the discovery and manufacture of drugs in space may one day become practical, affordable—and, perhaps, commonplace.
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Follow our daily updated Social Media pages for the latest news, event,curiosities and fun.
We are honored to be invited to ESA’s upcoming workshop “In-Orbit Economy” on July 20, 2021, from 9:45AM to 13:00PM CEST, live on WebEx. President & CEO Dr. Ferenc Darvas will join the roundtable discussion and talk about how to bridge the gap between zero gravity...
Published May 7, 2021 on 24.hu In the last few months, in addition to vaccine developments against the coronavirus, little has been heard of regarding what efforts have been made to develop new medicines for the treatment of already covid infected patients. Regarding...
Participants: InnoStudio, Inc. & CycloLab Ltd.Oral presentation by Dr. Gergő Mezőhegyi - Space chemistry and global health: Drug development against COVID-19 in space -, is confirmed on the 23rd of April, between 10.00am-11.00am under the session : Space and...
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
